Back

IL-10 / IL-6 serum ratio as a prognosis marker of STEMI

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Acute Coronary Syndromes ePosters Biomarkers ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Simon Leboube

University Hospital of Lausanne, Lausanne (Switzerland)

238 More presentations in this session

Presentation thumbnail
Prevalence of thrombophilia and antiphospholipid syndrome in myocardial infarction with non-obstructive coronary arteries and cryptogenic stroke
Miss S. Kruchinova (Krasnodar, RU)
Abstract Slides
Presentation thumbnail
Impact of admission serum acid uric levels on in-hospital outcomes in patients with acute coronary syndrome
Doctor M. Centola (Desio, IT)
Abstract Slides
Presentation thumbnail
Clinical predictors and angiographic features of acute coronary syndromes caused by systemic embolism
Mr A. Jeronimo (Madrid, ES)
Abstract Slides
Presentation thumbnail
Morphological characteristics of plaque erosion with noncritical coronary stenosis: an optical coherence tomography study
Doctor C. Fang (Harbin, CN)
Abstract Slides
Presentation thumbnail
Metformin exerts cardioprotection via attenuating mitochondrial fission in cardiac ischaemia-reperfusion injury in rats
Doctor T. Clements (Chiang Mai, TH)
Abstract Slides

Access the full session

Session thumbnail
Acute Coronary Syndromes ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Assessing the predictive power of biomarkers in ST-segment elevation myocardial infarction
29 June 2021
thumbnail
Congress Presentation
The role of intravascular laser irradiation of blood affecting IL-6 in hypertensive patients
4 April 2025
thumbnail
Congress Presentation
Interleukin-6 plasma levels are elevated in patients with acute myocardial infarction and predict death or recurrent infarction within 1 year - a case-control study
26 August 2023
thumbnail
Congress Presentation
Machine learning for differentiating shock types using inflammatory markers
14 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources